Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 4785 - 4792 of 11616 results
INSIGHT: California’s Privacy Act—Watch for an Expanding Private Right of Action
April 29, 2019| News
Aggressive ICE Tactics Set Up Heavyweight Clash In Mass.
April 29, 2019| News
Health Care Fraud Investigations and Litigation Offer Unexpected Lessons for Bankruptcy Counsel
April 25, 2019| Blog| Viewpoint
“Interim Measures” in Arbitration: Requiring Pre-Hearing Security for Payment of an Eventual Final Award
April 25, 2019| Blog| Viewpoint
Tenth Circuit Affirms Extraterritorial Reach of SEC Enforcement of the Federal Securities Laws
April 25, 2019| Blog| Viewpoint
DC Paid Leave Tax Begins Earlier Than Expected
April 25, 2019| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.